ArticleCureus2025
Lymphoma-Associated Multifocal Motor Neuropathy With Conduction Block in a Patient Recently Diagnosed With HIV.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Patterns of motor nerve demyelination and their prognostic significance in multifocal motor neuropathy.IBRO neuroscience reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multifocal motor neuropathy with conduction block (MMNCB) is a rare acquired immune-mediated demyelinating neuropathy that affects peripheral motor nerves, presenting as asymmetric, usually upper limb weakness without sensory impairment. Its concurrence with non-Hodgkin lymphoma (NHL) is an exceedingly rare phenomenon. This case describes a patient who presented with sequential bilateral foot drop starting from the left foot, with an ensuing weak hand grip. She was discovered to have cervical and occipital lymphadenopathy, which occasioned further blood work and tissue diagnosis. Her electrodiagnostic studies showed multiple asymmetric motor conduction blocks, normal distal motor latencies, and sensory studies consistent with a diagnosis of MMNCB. Her lymph node biopsy revealed diffuse large B-cell lymphoma (DLBCL). She could not afford intravenous immunoglobulin (IVIG); hence, pulse intravenous methylprednisolone was tried with no response. While her blood work showed a new diagnosis of HIV infection, her antiganglioside antibody panel was negative for anti-GM1 antibodies. Fortunately, her weakness began to improve in the third month of her chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP). Case reports have only provided the association of MMNCB and lymphoma. How each condition influences the other's manifestation, treatment, and prognosis is still poorly understood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.